Impact of Adjuvant Chemotherapy on Variant Histology of Upper Tract Urothelial Carcinoma: A Propensity Score-Matched Cohort Analysis
Journal
Frontiers in oncology
Journal Volume
12
Date Issued
2022
Author(s)
Lo, Chi-Wen
Li, Wei-Ming
Ke, Hung-Lung
Chang, Yi-Huei
Wu, Hsi-Chin
Chen, I-Hsuan Alan
Lin, Jen-Tai
Tseng, Jen-Shu
Lin, Wun-Rong
Jiang, Yuan-Hong
Lee, Yu-Khun
Tsai, Chung-You
Chung, Shiu-Dong
Hsueh, Thomas Y
Chiu, Allen W
Jou, Yeong-Chin
Cheong, Ian-Seng
Chen, Yung-Tai
Chen, Jih-Sheng
Chiang, Bing-Juin
Yu, Chih-Chin
Lin, Wei Yu
Wu, Chia-Chang
Chen, Chuan-Shu
Weng, Han-Yu
Tsai, Yao-Chou
Abstract
The advantage of adjuvant chemotherapy for upper urinary tract urothelial cancer (UTUC) has been reported, whereas its impact on upper tract cancer with variant histology remains unclear. We aimed to answer the abovementioned question with our real-world data.
Subjects
UTUC; adjuvant chemotherapy; nephroureterectomy; upper urinary tract urothelial cancer; variant histology
SDGs
Publisher
FRONTIERS MEDIA SA
Type
journal article